{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:05:35Z","timestamp":1793379935783,"version":"4.5.0"},"reference-count":136,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>mRNA vaccines represent a revolutionary advance in vaccinology, boasting advantages like rapid development, robust immunogenicity and flexible antigen design over traditional vaccines. This review systematically summarizes the core research progress of mRNA vaccines, including their structural composition with five functional elements and novel subtypes (linear mRNA, self-amplifying RNA, circular RNA) with unique biological characteristics and application value. It elaborates on the immune activation mechanism of mRNA vaccines, which mimic natural viral infection to trigger both innate and adaptive immunity, and analyzes mainstream delivery systems (lipid nanoparticles, dendritic cells, protamine, exosomes, polymers) with their respective performance, advantages and bottlenecks. This review also details the clinical application status of mRNA vaccines in infectious diseases (influenza, rabies, monkeypox, SARS-CoV-2, HIV, parasites) and cancer therapy, highlighting promising preclinical and clinical results of candidate vaccines and combined therapeutic regimens. Additionally, it addresses the current limitations of mRNA vaccines, such as delivery inefficiency, production costs, and cold chain constraints. Finally, this review prospects the future development direction, emphasizing that the optimization of delivery systems, antigen design and production processes will further promote the clinical translation and diversified application of mRNA vaccines in disease prevention and treatment.<\/jats:p>","DOI":"10.3390\/vaccines14030202","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:31:32Z","timestamp":1772098292000},"page":"202","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["From Design to Clinical Use: mRNA Vaccines for Infectious Diseases and Cancer"],"prefix":"10.3390","volume":"14","author":[{"given":"Yulin","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Pathogenic Biology, School of Basic Medicine, Cheeloo College of Medicine, Shandong University, Jinan 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Pathogenic Biology, School of Basic Medicine, Cheeloo College of Medicine, Shandong University, Jinan 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cong","sequence":"additional","affiliation":[{"name":"Department of Pathogenic Biology, School of Basic Medicine, Cheeloo College of Medicine, Shandong University, Jinan 250012, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Gote, V., Bolla, P.K., Kommineni, N., Butreddy, A., Nukala, P.K., Palakurthi, S.S., and Khan, W. (2023). A Comprehensive Review of mRNA Vaccines. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032700"},{"key":"ref_2","first-page":"1397","article-title":"Characterization of a Messenger RNA Polynucleotide Vaccine Vector","volume":"55","author":"Conry","year":"1995","journal-title":"Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA Vaccines\u2014A New Era in Vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2300006","DOI":"10.1002\/anbr.202300006","article-title":"Ionizable Lipid Nanoparticles for mRNA Delivery","volume":"3","author":"Tang","year":"2023","journal-title":"Adv. NanoBiomed Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tibtech.2004.04.006","article-title":"Codon Bias and Heterologous Protein Expression","volume":"22","author":"Gustafsson","year":"2004","journal-title":"Trends Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.biomaterials.2017.11.034","article-title":"Emergence of Synthetic mRNA: In Vitro Synthesis of mRNA and Its Applications in Regenerative Medicine","volume":"156","author":"Kwon","year":"2018","journal-title":"Biomaterials"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of Therapeutic Proteins after Delivery of Chemically Modified mRNA in Mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41587-024-02174-7","article-title":"Branched Chemically Modified Poly(a) Tails Enhance the Translation Capacity of mRNA","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.ymthe.2025.03.060","article-title":"The Advent of Clinical Self-Amplifying RNA Vaccines","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Silva-Pilipich, N., Beloki, U., Salaberry, L., and Smerdou, C. (2024). Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19. Vaccines, 12.","DOI":"10.3390\/vaccines12030318"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1016\/j.vaccine.2016.05.046","article-title":"Self-Adjuvanted mRNA Vaccines Induce Local Innate Immune Responses That Lead to a Potent and Boostable Adaptive Immunity","volume":"34","author":"Kowalczyk","year":"2016","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"126883","DOI":"10.1016\/j.vaccine.2025.126883","article-title":"Sa-mRNA Influenza Vaccine Raises a Higher and More Durable Immune Response than mRNA Vaccine in Preclinical Models","volume":"51","author":"Chang","year":"2025","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.omtn.2023.04.021","article-title":"Self-Replicating RNA Nanoparticle Vaccine Elicits Protective Immune Responses against SARS-CoV-2","volume":"32","author":"Lin","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1473-3099(23)00734-X","article-title":"Self-Amplifying RNA Vaccines against Antigenically Distinct SARS-CoV-2 Variants","volume":"24","author":"Herfst","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.apsb.2023.08.034","article-title":"Cancer Immunotherapy with Enveloped Self-Amplifying mRNA CARG-2020 That Modulates IL-12, IL-17 and PD-L1 Pathways to Prevent Tumor Recurrence","volume":"14","author":"Chen","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The Biogenesis, Biology and Characterization of Circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"153639","DOI":"10.1016\/j.prp.2021.153639","article-title":"CiRS-7\/CDR1as; an Oncogenic Circular RNA as a Potential Cancer Biomarker","volume":"227","author":"Rahmati","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.14336\/AD.2019.0920","article-title":"Biogenesis, Features, Functions, and Disease Relationships of a Specific Circular RNA: CDR1as","volume":"11","author":"Guo","year":"2020","journal-title":"Aging Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1007\/s11033-022-07666-w","article-title":"Rheumatoid Arthritis Fibroblast-like Synoviocytes Maintain Tumor-like Biological Characteristics through ciRS-7-Dependent Regulation of miR-7","volume":"49","author":"Hu","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1261\/rna.048272.114","article-title":"Efficient Backsplicing Produces Translatable Circular mRNAs","volume":"21","author":"Wang","year":"2015","journal-title":"RNA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.7536344","article-title":"Initiation of Protein Synthesis by the Eukaryotic Translational Apparatus on Circular RNAs","volume":"268","author":"Chen","year":"1995","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12943-020-01224-3","article-title":"The Role of N6-Methyladenosine (m6A) Modification in the Regulation of circRNAs","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"12022","DOI":"10.3748\/wjg.v21.i42.12022","article-title":"Nanoparticles for Targeted Delivery of Therapeutics and Small Interfering RNAs in Hepatocellular Carcinoma","volume":"21","author":"Varshosaz","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1038\/s41467-018-06936-1","article-title":"Cell Specific Delivery of Modified mRNA Expressing Therapeutic Proteins to Leukocytes","volume":"9","author":"Veiga","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_25","first-page":"349","article-title":"Progress toward development of novel coronavirus mRNA vaccines","volume":"26","author":"Zhang","year":"2020","journal-title":"Chin. Cent. Dis. Control. Prev."},{"key":"ref_26","first-page":"661","article-title":"mRNA technology for the development of vaccines against infectious diseases","volume":"40","author":"Ke","year":"2020","journal-title":"Chin. J. Microbiol. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2\u2014Preliminary Report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1093\/nar\/gky177","article-title":"An Origin of the Immunogenicity of in Vitro Transcribed RNA","volume":"46","author":"Mu","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector with Increased Translational Capacity and Biological Stability","volume":"16","author":"Muramatsu","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-Modified mRNA Vaccines Induce Potent T Follicular Helper and Germinal Center B Cell Responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s12951-025-03560-2","article-title":"Novel Adjuvant Delivery System Constructed by Alum-Emulsion Hybrid Nanoparticles with TLR9 Agonists Boosts Vaccine Immunity","volume":"23","author":"Zeng","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA Neoantigen Vaccines Prime Long-Lived CD8+ T Cells in Pancreatic Cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"199601","DOI":"10.1016\/j.virusres.2025.199601","article-title":"Accelerating Vaccine Development: Plug-and-Play Platforms for Emerging Infectious Diseases","volume":"358","author":"Yang","year":"2025","journal-title":"Virus Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lu, B., Lim, J.M., Yu, B., Song, S., Neeli, P., Sobhani, N., K, P., Bonam, S.R., Kurapati, R., and Zheng, J. (2024). The Next-Generation DNA Vaccine Platforms and Delivery Systems: Advances, Challenges and Prospects. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1332939"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e52445","DOI":"10.15252\/embr.202152445","article-title":"Linking Transport and Translation of mRNAs with Endosomes and Mitochondria","volume":"22","author":"Devan","year":"2021","journal-title":"Embo Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e3089","DOI":"10.1002\/jgm.3089","article-title":"Transcutaneous Delivery of DNA\/mRNA for Cancer Therapeutic Vaccination","volume":"21","author":"Sun","year":"2019","journal-title":"J. Gene Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid Nanoparticles\u2014From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility","volume":"28","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-Occurring Cholesterol Analogues in Lipid Nanoparticles Induce Polymorphic Shape and Enhance Intracellular Delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The Role of Helper Lipids in Lipid Nanoparticles (LNPs) Designed for Oligonucleotide Delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.bpj.2009.07.001","article-title":"Sphingosine-1-Phosphate as an Amphipathic Metabolite: Its Properties in Aqueous and Membrane Environments","volume":"97","author":"Collado","year":"2009","journal-title":"Biophys. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An Ionizable Lipid Toolbox for RNA Delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/mp3005337","article-title":"Assessing the Heterogeneity Level in Lipid Nanoparticles for siRNA Delivery: Size-Based Separation, Compositional Heterogeneity, and Impact on Bioperformance","volume":"10","author":"Zhang","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement Activation-Related Pseudoallergy: A Stress Reaction in Blood Triggered by Nanomedicines and Biologicals","volume":"61","author":"Szebeni","year":"2014","journal-title":"Mol. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","article-title":"Charge-Assisted Stabilization of Lipid Nanoparticles Enables Inhaled mRNA Delivery for Mucosal Vaccination","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2409812","DOI":"10.1002\/adma.202409812","article-title":"Simplified Lipid Nanoparticles for Tissue- and Cell-Targeted mRNA Delivery Facilitate Precision Tumor Therapy in a Lung Metastasis Mouse Model","volume":"36","author":"Fei","year":"2024","journal-title":"Adv. Mater."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"31530","DOI":"10.1021\/jacs.5c05367","article-title":"Breaking Endosomal Barriers: Thiol-Mediated Uptake Lipid Nanoparticles for Efficient mRNA Vaccine Delivery","volume":"147","author":"Lian","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","article-title":"Dendritic Cell Subsets in T Cell Programming: Location Dictates Function","volume":"19","author":"Eisenbarth","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ccell.2019.05.005","article-title":"Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8+ T Cell Apoptosis","volume":"35","author":"Qiao","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1084\/jem.172.2.631","article-title":"Dendritic Cells Pulsed with Protein Antigens in Vitro Can Prime Antigen-Specific, MHC-Restricted T Cells in Situ","volume":"172","author":"Inaba","year":"1990","journal-title":"J. Exp. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2014.08.011","article-title":"The Potential of Antigen and TriMix Sonoporation Using mRNA-Loaded Microbubbles for Ultrasound-Triggered Cancer Immunotherapy","volume":"194","author":"Dewitte","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41551-024-01208-4","article-title":"Dendritic-Cell-Targeting Virus-like Particles as Potent mRNA Vaccine Carriers","volume":"9","author":"Yin","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41563-025-02284-w","article-title":"Albumin-Recruiting Lipid Nanoparticle Potentiates the Safety and Efficacy of mRNA Vaccines by Avoiding Liver Accumulation","volume":"24","author":"Feng","year":"2025","journal-title":"Nat. Mater."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Jarzebska, N.T., Mellett, M., Frei, J., K\u00fcndig, T.M., and Pascolo, S. (2021). Protamine-Based Strategies for RNA Transfection. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13060877"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40425-019-0520-5","article-title":"Phase Ib Evaluation of a Self-Adjuvanted Protamine Formulated mRNA-Based Active Cancer Immunotherapy, BI1361849 (CV9202), Combined with Local Radiation Treatment in Patients with Stage IV Non-Small Cell Lung Cancer","volume":"7","author":"Papachristofilou","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/CJI.0b013e3181a00068","article-title":"Direct Injection of Protamine-Protected mRNA: Results of a Phase 1\/2 Vaccination Trial in Metastatic Melanoma Patients","volume":"32","author":"Weide","year":"2009","journal-title":"J. Immunother."},{"key":"ref_58","unstructured":"Kramps, T., and Elbers, K. (2017). Generation of Immunostimulating 130 Nm Protamine\u2013RNA Nanoparticles, Springer."},{"key":"ref_59","first-page":"1","article-title":"Messenger RNA-Based Vaccines with Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity","volume":"34","author":"Duchardt","year":"2011","journal-title":"J. Immunother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4161\/rna.22269","article-title":"Developing mRNA-Vaccine Technologies","volume":"9","author":"Schlake","year":"2012","journal-title":"RNA Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1182\/blood-2009-11-247817","article-title":"Particle Size and Activation Threshold: A New Dimension of Danger Signaling","volume":"115","author":"Rettig","year":"2010","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/eji.200635910","article-title":"Therapeutic Anti-Tumor Immunity Triggered by Injections of Immunostimulating Single-Stranded RNA","volume":"36","author":"Scheel","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(17)31665-3","article-title":"Safety and Immunogenicity of a mRNA Rabies Vaccine in Healthy Adults: An Open-Label, Non-Randomised, Prospective, First-in-Human Phase 1 Clinical Trial","volume":"390","author":"Alberer","year":"2017","journal-title":"Lancet"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.colsurfb.2009.04.026","article-title":"Synthesis and Characterization of Stearyl Protamine and Investigation of Their Complexes with DNA for Gene Delivery","volume":"73","author":"Liu","year":"2009","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1021\/acs.molpharmaceut.5b00422","article-title":"Protamine\/DNA\/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: The Role of Protamine","volume":"12","author":"Puras","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_66","first-page":"127","article-title":"Exploration and practice of mRNA technology in vaccine development","volume":"55","author":"Liu","year":"2024","journal-title":"J. China Pharm. Univ."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.actbio.2023.07.024","article-title":"Harnessing Knee Joint Resident Mesenchymal Stem Cells in Cartilage Tissue Engineering","volume":"168","author":"Xu","year":"2023","journal-title":"Acta Biomater."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"110325","DOI":"10.1016\/j.cellsig.2022.110325","article-title":"Multifunctional Role of Exosomes in Viral Diseases: From Transmission to Diagnosis and Therapy","volume":"94","author":"Chaudhari","year":"2022","journal-title":"Cell. Signal."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Shen, M., Shen, Y., Fan, X., Men, R., Ye, T., and Yang, L. (2020). Roles of Macrophages and Exosomes in Liver Diseases. Front. Med., 7.","DOI":"10.3389\/fmed.2020.583691"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"17802","DOI":"10.1021\/acsnano.2c08774","article-title":"Exosomes\u2014Nature\u2019s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics","volume":"16","author":"Tenchov","year":"2022","journal-title":"ACS Nano"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"113974","DOI":"10.1016\/j.addr.2021.113974","article-title":"Biomembrane-Based Nanostructures for Cancer Targeting and Therapy: From Synthetic Liposomes to Natural Biomembranes and Membrane-Vesicles","volume":"178","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.matt.2022.06.012","article-title":"Inhalable Dry Powder mRNA Vaccines Based on Extracellular Vesicles","volume":"5","author":"Popowski","year":"2022","journal-title":"Matter"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1039\/D2BM00480A","article-title":"Cell-Derived Extracellular Vesicles for CRISPR\/Cas9 Delivery: Engineering Strategies for Cargo Packaging and Loading","volume":"10","author":"Liang","year":"2022","journal-title":"Biomater. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.7150\/thno.62330","article-title":"Engineered Exosomes: Desirable Target-Tracking Characteristics for Cerebrovascular and Neurodegenerative Disease Therapies","volume":"11","author":"Xu","year":"2021","journal-title":"Theranostics"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41565-024-01785-0","article-title":"Direct Cytosolic Delivery of siRNA via Cell Membrane Fusion Using Cholesterol-Enriched Exosomes","volume":"19","author":"Zhuo","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"102033","DOI":"10.1016\/j.xcrm.2025.102033","article-title":"A Combined \u201cEat Me\/Don\u2019t Eat Me\u201d Strategy Based on Exosome for Acute Liver Injury Treatment","volume":"6","author":"Du","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_77","first-page":"298","article-title":"Optimal Conditions for Uptake of Exogenous DNA by Chinese Hamster Lung Cells Deficient in Hypoxanthine-Guanine Phosphoribosyltransferase","volume":"390","author":"Farber","year":"1975","journal-title":"Biochim. Et Biophys. Acta (BBA)-Nucleic Acids Protein Synth."},{"key":"ref_78","first-page":"1659","article-title":"In-Vitro Transcribed mRNA Delivery Using PLGA\/PEI Nanoparticles into Human Monocyte-Derived Dendritic Cells","volume":"18","author":"Sharifnia","year":"2019","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Tarach, P., and Janaszewska, A. (2021). Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062912"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/med.21479","article-title":"Chemical Modifications of Nucleic Acid Drugs and Their Delivery Systems for Gene-Based Therapy","volume":"38","author":"Chen","year":"2018","journal-title":"Med. Res. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.7150\/thno.57456","article-title":"Thyroid Hormone plus Dual-Specificity Phosphatase-5 siRNA Increases the Number of Cardiac Muscle Cells and Improves Left Ventricular Contractile Function in Chronic Doxorubicin-Injured Hearts","volume":"11","author":"Tan","year":"2021","journal-title":"Theranostics"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Kabut, J., Stopyra, M., Nafalska, N., St\u0119pie\u0144, G.J., Miciak, M., Jezierza\u0144ski, M., Furgo\u0142, T., Feret, K., and Gisterek-Grocholska, I. (2025). mRNA-Based Neoantigen Vaccines in Pancreatic Ductal Adenocarcinoma (PDAC)\u2014A Promising Avenue in Cancer Immunotherapy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262210988"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Maeng, H.M., Moore, B.N., Bagheri, H., Steinberg, S.M., Inglefield, J., Dunham, K., Wei, W.-Z., Morris, J.C., Terabe, M., and England, L.C. (2021). Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine against HER2 Shows Safety and Preliminary Clinical Efficacy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.789078"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.ymthe.2024.04.036","article-title":"Development of an mRNA-Based Therapeutic Vaccine mHTV-03E2 for High-Risk HPV-Related Malignancies","volume":"32","author":"Wang","year":"2024","journal-title":"Mol. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ccell.2022.08.003","article-title":"Personalized Neoantigen Vaccine NEO-PV-01 with Chemotherapy and Anti-PD-1 as First-Line Treatment for Non-Squamous Non-Small Cell Lung Cancer","volume":"40","author":"Awad","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Haanen, J.B., L\u00fcke, F., Rengstl, B., Desuki, A., Heudobler, D., Mackensen, A., Wagner-Drouet, E., Klobuch, S., Sahin, U., and Preussner, L. (2022). Abstract CT002: BNT211: A Phase I Trial to Evaluate Safety and Efficacy of CLDN6 CAR-T Cells and CARVac-Mediated in Vivo Expansion in Patients with CLDN6-Positive Advanced Solid Tumors. Cancer Res., 82.","DOI":"10.1158\/1538-7445.AM2022-CT002"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41467-022-28279-8","article-title":"Combining P53 mRNA Nanotherapy with Immune Checkpoint Blockade Reprograms the Immune Microenvironment for Effective Cancer Therapy","volume":"13","author":"Xiao","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The Dawn of mRNA Vaccines: The COVID-19 Case","volume":"333","author":"Verbeke","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2019.05.032","article-title":"Therapeutic mRNA Delivery to Leukocytes","volume":"305","author":"Kon","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e000329","DOI":"10.1136\/jitc-2019-000329","article-title":"TriMix and Tumor Antigen mRNA Electroporated Dendritic Cell Vaccination plus Ipilimumab: Link between T-Cell Activation and Clinical Responses in Advanced Melanoma","volume":"8","author":"Keersmaecker","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e20241454","DOI":"10.1084\/jem.20241454","article-title":"Membrane-IL12 Adjuvant mRNA Vaccine Polarizes Pre-Effector T Cells for Optimized Tumor Control","volume":"222","author":"Peng","year":"2025","journal-title":"J. Exp. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1158\/1078-0432.CCR-15-1509","article-title":"Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines","volume":"22","author":"Vormehr","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC Class II Epitopes Drive Therapeutic Immune Responses to Cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1093\/infdis\/jiae329","article-title":"Safety and Immunogenicity of mRNA-1010, an Investigational Seasonal Influenza Vaccine, in Healthy Adults: Final Results from a Phase 1\/2 Randomized Trial","volume":"231","author":"Ananworanich","year":"2025","journal-title":"J. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"126847","DOI":"10.1016\/j.vaccine.2025.126847","article-title":"A Phase 3 Randomized Safety and Immunogenicity Trial of mRNA-1010 Seasonal Influenza Vaccine in Adults","volume":"50","author":"Soens","year":"2025","journal-title":"Vaccine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa2416779","article-title":"Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine","volume":"393","author":"McVinnie","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Mazunina, E.P., Gushchin, V.A., Kleymenov, D.A., Siniavin, A.E., Burtseva, E.I., Shmarov, M.M., Mukasheva, E.A., Bykonia, E.N., Kozlova, S.R., and Evgrafova, E.A. (2024). Trivalent mRNA Vaccine-Candidate against Seasonal Flu with Cross-Specific Humoral Immune Response. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1381508"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.vaccine.2024.02.059","article-title":"Real-World Effectiveness of Seasonal Influenza Vaccination and Age as Effect Modifier: A Systematic Review, Meta-Analysis and Meta-Regression of Test-Negative Design Studies","volume":"42","author":"Guo","year":"2024","journal-title":"Vaccine"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","article-title":"Influenza Vaccine: The Challenge of Antigenic Drift","volume":"25","author":"Carrat","year":"2007","journal-title":"Vaccine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41541-024-00925-w","article-title":"Safety and Efficacy Assessment of an mRNA Rabies Vaccine in Dogs, Rodents, and Cynomolgus Macaques","volume":"9","author":"Li","year":"2024","journal-title":"Npj Vaccines"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41541-025-01098-w","article-title":"Optimizing Rabies mRNA Vaccine Efficacy via RABV-G Structural Domain Screening and Heterologous Prime-Boost Immunization","volume":"10","author":"Li","year":"2025","journal-title":"Npj Vaccines"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Schnee, M., Vogel, A.B., Voss, D., Petsch, B., Baumhof, P., Kramps, T., and Stitz, L. (2016). An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs. PLoS Neglected Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004746"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-017-0032-6","article-title":"Unmodified mRNA in LNPs Constitutes a Competitive Technology for Prophylactic Vaccines","volume":"2","author":"Lutz","year":"2017","journal-title":"NPJ Vaccines"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit Recombinant Vaccine Protects against Monkeypox1","volume":"177","author":"Heraud","year":"2006","journal-title":"J. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","article-title":"Immunogenicity and Protection Efficacy of Monovalent and Polyvalent Poxvirus Vaccines That Include the D8 Antigen","volume":"355","author":"Sakhatskyy","year":"2006","journal-title":"Virology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1016\/j.vaccine.2020.07.018","article-title":"Short-Term and Longer-Term Protective Immune Responses Generated by Subunit Vaccination with Smallpox A33, B5, L1 or A27 Proteins Adjuvanted with Aluminum Hydroxide and CpG in Mice Challenged with Vaccinia Virus","volume":"38","author":"Xiao","year":"2020","journal-title":"Vaccine"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e28983","DOI":"10.1002\/jmv.28983","article-title":"Various Mpox Recombinant Subunits Induce Broadly Reactive Antibodies against Orthopoxvirus in Mice","volume":"95","author":"Jiang","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1038\/s41467-023-41628-5","article-title":"mRNA Vaccines Encoding Fusion Proteins of Monkeypox Virus Antigens Protect Mice from Vaccinia virus Challenge","volume":"14","author":"Hou","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","article-title":"A Multivalent mRNA Monkeypox Virus Vaccine (BNT166) Protects Mice and Macaques from Orthopoxvirus Disease","volume":"187","author":"Zuiani","year":"2024","journal-title":"Cell"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMra1808246","article-title":"Zika virus infection\u2014After the pandemic","volume":"381","author":"Musso","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika Virus Protection by a Single Low-Dose Nucleoside-Modified mRNA Vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.03.016","article-title":"Modified mRNA Vaccines Protect against Zika Virus Infection","volume":"169","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.ymthe.2018.07.010","article-title":"A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika","volume":"26","author":"Erasmus","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/infdis\/jiz338","article-title":"Protective Efficacy of Nucleic Acid Vaccines against Transmission of Zika Virus during Pregnancy in Mice","volume":"220","author":"Jagger","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/s41591-021-01583-4","article-title":"BNT162b2 and mRNA-1273 COVID-19 Vaccine Effectiveness against the SARS-CoV-2 Delta Variant in Qatar","volume":"27","author":"Tang","year":"2021","journal-title":"Nat. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41591-021-01446-y","article-title":"mRNA-1273 COVID-19 Vaccine Effectiveness against the B.1.1.7 and B.1.351 Variants and Severe COVID-19 Disease in Qatar","volume":"27","author":"Chemaitelly","year":"2021","journal-title":"Nat. Med."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"G\u00fcnl, F., Mecate-Zambrano, A., Rehl\u00e4nder, S., Hinse, S., Ludwig, S., and Brunotte, L. (2021). Shooting at a Moving Target\u2014Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development. Vaccines, 9.","DOI":"10.3390\/vaccines9101052"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41591-022-01753-y","article-title":"Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta Variants","volume":"28","author":"Tseng","year":"2022","journal-title":"Nat. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"eabj9815","DOI":"10.1126\/sciadv.abj9815","article-title":"Preclinical Evaluation of a SARS-CoV-2 mRNA Vaccine PTX-COVID19-B","volume":"8","author":"Liu","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/S2666-5247(21)00280-9","article-title":"Safety and Immunogenicity of the SARS-CoV-2 ARCoV mRNA Vaccine in Chinese Adults: A Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial","volume":"3","author":"Chen","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for Adverse Events after COVID-19 mRNA Vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000000852","article-title":"Immunization of HIV-1-Infected Persons with Autologous Dendritic Cells Transfected with mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial","volume":"71","author":"Gandhi","year":"2016","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr."},{"key":"ref_126","unstructured":"(2025, August 05). Moderna Announces First Participant Dosed in Phase 1 Study of Its HIV Trimer mRNA Vaccine | FirstWord Pharma. Available online: https:\/\/firstwordpharma.com\/story\/5524923."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","article-title":"HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies","volume":"45","author":"Steichen","year":"2016","journal-title":"Immunity"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Mu, Z., Haynes, B.F., and Cain, D.W. (2021). HIV mRNA Vaccines\u2014Progress and Future Paths. Vaccines, 9.","DOI":"10.3390\/vaccines9020134"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"eadr8382","DOI":"10.1126\/science.adr8382","article-title":"Vaccination with mRNA-Encoded Nanoparticles Drives Early Maturation of HIV bnAb Precursors in Humans","volume":"389","author":"Willis","year":"2025","journal-title":"Science"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Luo, F., Zheng, L., Hu, Y., Liu, S., Wang, Y., Xiong, Z., Hu, X., and Tan, F. (2017). Induction of Protective Immunity against Toxoplasma Gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-Amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP). Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00605"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40249-025-01332-6","article-title":"A Novel Combined Quadrivalent Self-Amplifying mRNA-LNP Vaccine Provokes Protective Immunity against Acute and Chronic Toxoplasmosis in Mice","volume":"14","author":"Wu","year":"2025","journal-title":"Infect. Dis. Poverty"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41598-020-79427-3","article-title":"A Chemokine-Fusion Vaccine Targeting Immature Dendritic Cells Elicits Elevated Antibody Responses to Malaria Sporozoites in Infant Macaques","volume":"11","author":"Luo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-023-00783-y","article-title":"mRNA Vaccines Expressing Malaria Transmission-Blocking Antigens Pfs25 and Pfs230D1 Induce a Functional Immune Response","volume":"9","author":"Scaria","year":"2024","journal-title":"Npj Vaccines"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.vaccine.2020.12.070","article-title":"Proof-of-Concept of a Low-Dose Unmodified mRNA-Based Rabies Vaccine Formulated with Lipid Nanoparticles in Human Volunteers: A Phase 1 Trial","volume":"39","author":"Aldrich","year":"2021","journal-title":"Vaccine"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Zhong, Z., Portela Catani, J.P., Mc Cafferty, S., Couck, L., Van Den Broeck, W., Gorl\u00e9, N., Vandenbroucke, R.E., Devriendt, B., Ulbert, S., and Cnops, L. (2019). Immunogenicity and Protection Efficacy of a Naked Self-Replicating mRNA-Based Zika Virus Vaccine. Vaccines, 7.","DOI":"10.3390\/vaccines7030096"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41541-021-00420-6","article-title":"Development of Multivalent mRNA Vaccine Candidates for Seasonal or Pandemic Influenza","volume":"6","author":"Chivukula","year":"2021","journal-title":"Npj Vaccines"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/3\/202\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T05:12:10Z","timestamp":1772255530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/3\/202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":136,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["vaccines14030202"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14030202","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}